ARThe Brazilian Minister of Agriculture and Livestock, André de Paula, visited an Argentine biotechnology company, Biogénesis Bagó, to formally launch Brazil’s new antigen bank against bovine tuberculosis. This initiative aims to provide a sanitary safeguard in case of a potential outbreak, allowing the production of up to 10 million vaccine doses. The bank, managed by the Brazilian state-owned laboratory Tecpar, was contracted to store antigens at -170°C in an Argentine facility. Brazil had previously ended its nationwide vaccination program after over five decades, emphasizing the need for alternative protective measures. The agreement involves a $10 million investment and includes strategic reserves from other countries like Argentina, the U.S., Canada, and South Korea.
Bias read (Center): The article presents a factual account of a technical and economic collaboration between Brazil and Argentina, focusing on agricultural policy and public health strategies. While it highlights Brazil’s decision to rely on an Argentine company for a critical infrastructure project, there is no overt褒
